Eric Wooltorton
Impact in
- Psychiatry and Mental health top 5%
- Dementia and Cognitive Impairment Research
- Schizophrenia research and treatment
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 9
-
- Drug-Induced Hepatotoxicity and Protection 3
- Alkaloids: synthesis and pharmacology 2
- Co-authors
- Barbara Sibbald (1 shared paper)PAUL J. HENDRY (2 shared papers)Tina P. Haliotis (1 shared paper)Alexander Ross Morton (1 shared paper)Kathryn Williams (1 shared paper)George A. Wells (1 shared paper)J. S. Lawson (1 shared paper)Jacques Lemelin (1 shared paper)
- Journals
- Canadian Medical Association Journal (28 papers)Biological Psychiatry (1 paper)DNA and Cell Biology (1 paper)MedEdPublish (1 paper)Europe PMC (PubMed Central) (1 paper)
- Partner nations
- Canada
In The Last Decade
Eric Wooltorton
63 papers receiving 938 citations
Peers
Comparison fields: 5 of 96
- Psychiatry and Mental health 361
- Geriatrics and Gerontology 66
- Toxicology 43
- Pharmacology 67
- Dermatology 35
Countries citing papers authored by Eric Wooltorton
This map shows the geographic impact of Eric Wooltorton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Wooltorton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Wooltorton more than expected).
Fields of papers citing papers by Eric Wooltorton
This network shows the impact of papers produced by Eric Wooltorton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Wooltorton. The network helps show where Eric Wooltorton may publish in the future.
Co-authors
The 23 scholars most cited alongside Eric Wooltorton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials. | 2002 | 189 |
| 2 | 2004 | 141 | |
| 3 | 2007 | 50 | |
| 4 | Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias. | 2002 | 48 |
| 5 | Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure. | 2002 | 45 |
| 6 | Antipsychotic clozapine (Clozaril): myocarditis and cardiovascular toxicity. | 2002 | 42 |
| 7 | Ephedra/ephedrine: cardiovascular and CNS effects. | 2002 | 31 |
| 8 | Salmeterol (Serevent) asthma trial halted early. | 2003 | 27 |
| 9 | 2005 | 25 | |
| 10 | Herbal kava: reports of liver toxicity. | 2002 | 24 |
| 11 | 2005 | 24 | |
| 12 | Too much of a good thing? Toxic effects of vitamin and mineral supplements. | 2003 | 23 |
| 13 | Propofol: contraindicated for sedation of pediatric intensive care patients. | 2002 | 21 |
| 14 | 2005 | 19 | |
| 15 | Mefloquine: contraindicated in patients with mood, psychotic or seizure disorders. | 2002 | 18 |
| 16 | HIV drug stavudine (Zerit, d4T) and symptoms mimicking Guillain-Barré syndrome. | 2002 | 17 |
| 17 | Bupropion (Zyban, Wellbutrin SR): reports of deaths, seizures, serum sickness. | 2002 | 15 |
| 18 | Accutane (isotretinoin) and psychiatric adverse effects. | 2003 | 15 |
| 19 | Paroxetine (Paxil, Seroxat): increased risk of suicide in pediatric patients. | 2003 | 14 |
| 20 | Diane-35 (cyproterone acetate): safety concerns. | 2003 | 14 |
About Eric Wooltorton
Eric Wooltorton is a scholar working on Toxicology, Pharmacology, Public Health, Environmental and Occupational Health, Psychiatry and Mental health and Endocrinology, Diabetes and Metabolism, having authored 64 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (9 papers), Innovations in Medical Education (4 papers), Publishing and Scholarly Communication (4 papers), Reproductive Health and Contraception (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Academic Writing and Publishing (3 papers), Diabetes Treatment and Management (3 papers) and Alkaloids: synthesis and pharmacology (2 papers). The work is most often cited by research in Psychiatry and Mental health (361 citations), Geriatrics and Gerontology (66 citations), Toxicology (43 citations), Pharmacology (67 citations) and Dermatology (35 citations). Eric Wooltorton has collaborated with scholars based in Canada. Frequent co-authors include Barbara Sibbald, PAUL J. HENDRY, Tina P. Haliotis, Alexander Ross Morton, Kathryn Williams, George A. Wells, J. S. Lawson, Jacques Lemelin, Colla Jean Macdonald and Clare E. Liddy. Their work appears in journals such as Canadian Medical Association Journal, Biological Psychiatry, DNA and Cell Biology, MedEdPublish and Europe PMC (PubMed Central).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.